These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 24508696)

  • 1. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma of the eye: revealing hidden secrets, one at a time.
    Shields CL; Kels JG; Shields JA
    Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors.
    Bornfeld N; Biewald E; Bauer S; Temming P; Lohmann D; Zeschnigk M
    Dtsch Arztebl Int; 2018 Feb; 115(7):106-111. PubMed ID: 29510820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal metastasis revealing lung cancer.
    Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of uveal melanoma.
    Shields JA; Shields CL; De Potter P; Singh AD
    Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
    Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
    Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
    Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
    Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant tumors of the uveal tract.
    Shields JA; Young SE
    Curr Probl Cancer; 1980 Jul; 5(1):1-35. PubMed ID: 6996936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
    Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
    JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular melanoma.
    Laver NV; McLaughlin ME; Duker JS
    Arch Pathol Lab Med; 2010 Dec; 134(12):1778-84. PubMed ID: 21128775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveal melanoma dormancy: an acceptable clinical endpoint?
    Blanco PL; Lim LA; Miyamoto C; Burnier MN
    Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
    Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
    Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.